Replies to post #579373 on ORIONS Money Stocks

[Mark]

Phase 3 data, the data the other day was phase 2, halted now:

Los Gatos, Calif. , Dec. 28, 2022 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening infections, will host a conference call and audio-only webcast on Wednesday, January 25 , at 4:15 p.m. ET to provide a business and pipeline update, including a discussion of topline data from the Company’s Phase 3 study of AR-301 in adjunctive treatment of S. aureus ventilator associated pneumonia (VAP). The Company expects to publish topline data from AR-301 on January 25 , prior to the call. A question-and-answer session will follow management’s prepared remarks.